Review



e coli jm109  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 95

    Structured Review

    ATCC e coli jm109
    E Coli Jm109, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 486 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/e coli jm109/product/ATCC
    Average 95 stars, based on 486 article reviews
    e coli jm109 - by Bioz Stars, 2026-06
    95/100 stars

    Images



    Similar Products

    95
    ATCC e coli jm109
    E Coli Jm109, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/e coli jm109/product/ATCC
    Average 95 stars, based on 1 article reviews
    e coli jm109 - by Bioz Stars, 2026-06
    95/100 stars
      Buy from Supplier

    94
    ATCC e coli jm109 prk2013
    E Coli Jm109 Prk2013, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/e coli jm109 prk2013/product/ATCC
    Average 94 stars, based on 1 article reviews
    e coli jm109 prk2013 - by Bioz Stars, 2026-06
    94/100 stars
      Buy from Supplier

    95
    TaKaRa e coli jm109 cells
    E Coli Jm109 Cells, supplied by TaKaRa, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/e coli jm109 cells/product/TaKaRa
    Average 95 stars, based on 1 article reviews
    e coli jm109 cells - by Bioz Stars, 2026-06
    95/100 stars
      Buy from Supplier

    95
    TaKaRa e coli jm109
    E Coli Jm109, supplied by TaKaRa, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/e coli jm109/product/TaKaRa
    Average 95 stars, based on 1 article reviews
    e coli jm109 - by Bioz Stars, 2026-06
    95/100 stars
      Buy from Supplier

    93
    Addgene inc jm109 e coli strains
    Jm109 E Coli Strains, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/jm109 e coli strains/product/Addgene inc
    Average 93 stars, based on 1 article reviews
    jm109 e coli strains - by Bioz Stars, 2026-06
    93/100 stars
      Buy from Supplier

    95
    Zymo Research e coli strain jm109
    E Coli Strain Jm109, supplied by Zymo Research, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/e coli strain jm109/product/Zymo Research
    Average 95 stars, based on 1 article reviews
    e coli strain jm109 - by Bioz Stars, 2026-06
    95/100 stars
      Buy from Supplier

    95
    ATCC potent antimicrobial activity against e coli jm109
    ROS generation assessment using the fluorescent probe H2DCFDA after incubation of (a) bacteria ( S. aureus , <t>E.</t> <t>coli</t> , and P. aeruginosa ) and (b) human keratinocytes and fibroblasts with TeLigNPs. Results are reported as mean values ± SD ( n = 3).
    Potent Antimicrobial Activity Against E Coli Jm109, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/potent antimicrobial activity against e coli jm109/product/ATCC
    Average 95 stars, based on 1 article reviews
    potent antimicrobial activity against e coli jm109 - by Bioz Stars, 2026-06
    95/100 stars
      Buy from Supplier

    Image Search Results


    ROS generation assessment using the fluorescent probe H2DCFDA after incubation of (a) bacteria ( S. aureus , E. coli , and P. aeruginosa ) and (b) human keratinocytes and fibroblasts with TeLigNPs. Results are reported as mean values ± SD ( n = 3).

    Journal: RSC Advances

    Article Title: Tellurium nanoparticles as antimicrobial agents for multi-drug-resistant infections

    doi: 10.1039/d5ra02635k

    Figure Lengend Snippet: ROS generation assessment using the fluorescent probe H2DCFDA after incubation of (a) bacteria ( S. aureus , E. coli , and P. aeruginosa ) and (b) human keratinocytes and fibroblasts with TeLigNPs. Results are reported as mean values ± SD ( n = 3).

    Article Snippet: These nanoparticles exhibited potent antimicrobial activity against E. coli JM109, P. aeruginosa PAO1, and S. aureus ATCC 25923.

    Techniques: Incubation, Bacteria

    Assessment of E. coli BW25113 membrane integrity following treatment with BioTe or tellurite. (a–c) Representative SEM images of untreated cells (a), BioTe-treated cells (b), and tellurite-treated cells (c). Red arrows indicate membrane perforations in treated samples. Scale bars: 1 μm. (d–f) PI staining highlights membrane-compromised cells in the untreated control (d), BioTe-treated (e), and tellurite-treated (f) groups. (g–i) SYTO 9 staining shows all cells in untreated (g), BioTe-treated (h), and tellurite-treated (i) samples. (j–l) Bright-field images of the corresponding samples. Scale bars for fluorescence and bright-field images: 10 μm. (m) β-Galactosidase activity in culture supernatants of E. coli BL21(DE3) overexpressing lacZ , treated with BioTe (3× MIC), tellurite (3× MIC), or left untreated for 1 hour. Samples were analyzed via SEM, fluorescence staining, and β-galactosidase activity measurement. Data represent mean ± SD ( n = 3). Asterisks indicate statistically significant differences ( p < 0.05).

    Journal: RSC Advances

    Article Title: Tellurium nanoparticles as antimicrobial agents for multi-drug-resistant infections

    doi: 10.1039/d5ra02635k

    Figure Lengend Snippet: Assessment of E. coli BW25113 membrane integrity following treatment with BioTe or tellurite. (a–c) Representative SEM images of untreated cells (a), BioTe-treated cells (b), and tellurite-treated cells (c). Red arrows indicate membrane perforations in treated samples. Scale bars: 1 μm. (d–f) PI staining highlights membrane-compromised cells in the untreated control (d), BioTe-treated (e), and tellurite-treated (f) groups. (g–i) SYTO 9 staining shows all cells in untreated (g), BioTe-treated (h), and tellurite-treated (i) samples. (j–l) Bright-field images of the corresponding samples. Scale bars for fluorescence and bright-field images: 10 μm. (m) β-Galactosidase activity in culture supernatants of E. coli BL21(DE3) overexpressing lacZ , treated with BioTe (3× MIC), tellurite (3× MIC), or left untreated for 1 hour. Samples were analyzed via SEM, fluorescence staining, and β-galactosidase activity measurement. Data represent mean ± SD ( n = 3). Asterisks indicate statistically significant differences ( p < 0.05).

    Article Snippet: These nanoparticles exhibited potent antimicrobial activity against E. coli JM109, P. aeruginosa PAO1, and S. aureus ATCC 25923.

    Techniques: Membrane, Staining, Control, Fluorescence, Activity Assay

    Antibacterial and antibiofilm activity of Te and Te–SO NNs against E. coli . (a) Colony count variation and (b) antibacterial efficacy at different concentrations of Te and Te–SO NNs. (c) Fluorescence microscopy images of E. coli stained with SYTO 9 (live cells, green) and PI (membrane-compromised cells, red) following treatment with Te and Te–SO NNs (100 μg mL −1 ). SEM images depicting morphological changes in (d) planktonic E. coli cells and (e) E. coli biofilms after exposure to Te or Te–SO NNs (100 μg mL −1 ).

    Journal: RSC Advances

    Article Title: Tellurium nanoparticles as antimicrobial agents for multi-drug-resistant infections

    doi: 10.1039/d5ra02635k

    Figure Lengend Snippet: Antibacterial and antibiofilm activity of Te and Te–SO NNs against E. coli . (a) Colony count variation and (b) antibacterial efficacy at different concentrations of Te and Te–SO NNs. (c) Fluorescence microscopy images of E. coli stained with SYTO 9 (live cells, green) and PI (membrane-compromised cells, red) following treatment with Te and Te–SO NNs (100 μg mL −1 ). SEM images depicting morphological changes in (d) planktonic E. coli cells and (e) E. coli biofilms after exposure to Te or Te–SO NNs (100 μg mL −1 ).

    Article Snippet: These nanoparticles exhibited potent antimicrobial activity against E. coli JM109, P. aeruginosa PAO1, and S. aureus ATCC 25923.

    Techniques: Activity Assay, Fluorescence, Microscopy, Staining, Membrane

    In vivo therapeutic efficacy of Te NNs/PVA hydrogel on wounds co-infected with S. aureus and E. coli . (a) Representative images of wound healing progression in rats treated with PBS, PVA hydrogel, and Te NNs/PVA hydrogel at days 0, 4, 7, 10, and 14 (scale bar: 1 cm). (b) Bacterial culture images obtained from skin tissue samples across different treatment groups over the same period. (c) Quantitative analysis of wound healing rates from day 4 to day 14. (d) Residual bacterial counts at wound sites for each treatment group. Data are presented as mean ± standard deviation ( n = 5 per group); * p < 0.05, ** p < 0.01, compared to the Te NNs/PVA group.

    Journal: RSC Advances

    Article Title: Tellurium nanoparticles as antimicrobial agents for multi-drug-resistant infections

    doi: 10.1039/d5ra02635k

    Figure Lengend Snippet: In vivo therapeutic efficacy of Te NNs/PVA hydrogel on wounds co-infected with S. aureus and E. coli . (a) Representative images of wound healing progression in rats treated with PBS, PVA hydrogel, and Te NNs/PVA hydrogel at days 0, 4, 7, 10, and 14 (scale bar: 1 cm). (b) Bacterial culture images obtained from skin tissue samples across different treatment groups over the same period. (c) Quantitative analysis of wound healing rates from day 4 to day 14. (d) Residual bacterial counts at wound sites for each treatment group. Data are presented as mean ± standard deviation ( n = 5 per group); * p < 0.05, ** p < 0.01, compared to the Te NNs/PVA group.

    Article Snippet: These nanoparticles exhibited potent antimicrobial activity against E. coli JM109, P. aeruginosa PAO1, and S. aureus ATCC 25923.

    Techniques: In Vivo, Drug discovery, Infection, Standard Deviation

    Histological analysis of skin tissue from S. aureus and E. coli co-infected wounds following treatment with different dressings. (a) Hematoxylin and eosin (H&E) stained images and (b) Masson's trichrome stained images, illustrating the extent of bacterial infection and tissue regeneration after 7 and 14 days of treatment. Scale bar: 100 μm. Yellow arrows indicate neutrophils, while blue arrows highlight fibroblasts.

    Journal: RSC Advances

    Article Title: Tellurium nanoparticles as antimicrobial agents for multi-drug-resistant infections

    doi: 10.1039/d5ra02635k

    Figure Lengend Snippet: Histological analysis of skin tissue from S. aureus and E. coli co-infected wounds following treatment with different dressings. (a) Hematoxylin and eosin (H&E) stained images and (b) Masson's trichrome stained images, illustrating the extent of bacterial infection and tissue regeneration after 7 and 14 days of treatment. Scale bar: 100 μm. Yellow arrows indicate neutrophils, while blue arrows highlight fibroblasts.

    Article Snippet: These nanoparticles exhibited potent antimicrobial activity against E. coli JM109, P. aeruginosa PAO1, and S. aureus ATCC 25923.

    Techniques: Infection, Staining